| 26621/34347 | US=84 / Câncer Hamdan MH. Protein networks and protein phosphorylation in cancer. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 249-320. ISBN 978-0-471-74516-7. |
| 26622/34347 | US=84 / Câncer Hamdan MH. Ethical issues and initiatives relevant to cancer biomarkers. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 321-61. ISBN 978-0-471-74516-7. |
| 26623/34347 | US=92 / Biol/Mol Kaufmann SH. Apoptosis and alternative modes of cell death: the intrinsic pathway of apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 3-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; CASPASES; CARCINOGENESE; BCL-2; AIP; RESISTENCIA AS DROGAS; DROGAS ANTICANCER |
| 26624/34347 | US=92 / Biol/Mol Ricci MS, El-Deiry WS. Apoptosis and alternative modes of cell death: the extrinsic pathway of apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 31-54. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; TNF; FAS; TRAIL; NF-KB; QUIMIOTERAPIA; RECEPTOR MORTE; RECEPTOR CHAMARIZ; VIA EXTRINSECA; AUTOIMUNIDADE |
| 26625/34347 | US=92 / Biol/Mol Wouters BG, Chiu RK. Apoptosis and alternative modes of cell death: evaluating the importance of apoptosis and other determinants of cell death and survival. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 55-72. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; CLONOGENICA SOBREVIVENCIA; SENESCENCIA; TERAPIA DO CANCER |
| 26626/34347 | US=92 / Biol/Mol Ianzini F, Mackey MA. Apoptosis and alternative modes of cell death: mitotic catastrople. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 73-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. CATASTROFE MITOTICA; REGULACAO DO CICLO CELULAR; CICLINA B1; CELULAS ENDOPOLYPLOID; MITOSE; MEISIS; CARCINOGENESE; PROGRESSAO TUMORAL; RETARDADA DANOS NO DNA; SPCC |
| 26627/34347 | US=92 / Biol/Mol Djavaheri-Mergny M, Botti J, Codogno P. Apoptosis and alternative modes of cell death: autophagy and autophagic cell death. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 93-107. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. AUTOFAGIA; APOPTOSE; MORTE CELULAR; CANCER; MACROAUTOPHAGY; LISOSSOMO; TRANSDUCAO DE SINAL |
| 26628/34347 | US=92 / Biol/Mol McConkey DJ, Bondar V. Apoptosis and alternative modes of cell death: regulation and function of detachment-induced death (anoikis) in cancer progression and metastasis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 109-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 26629/34347 | US=92 / Biol/Mol McConkey DJ, Bondar V. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: structure and function of the telomere. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 125-44. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TELOMERASE; ALT; TUMORIGENESIS; INSTABILIDADE GENOMICA; ESTABILIDADE CROMOSSOMO; CANCER; ENVELHECIMENTO |
| 26630/34347 | US=92 / Biol/Mol Ramirez RD. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: overview of senescence. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 145-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. SENESCENCIA CELULAR; ENVELHECIMENTO; TELOMEROS; TELOMERASE; ALTERNATIVA PARA ALONGAR OS TELOMEROS; PROBLEMA DE REPLICACAO FINAL |
| 26631/34347 | US=92 / Biol/Mol Possemato R, Hahn WC. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: contributions of telomerase to tumorigenesis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 159-71. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TRANSCRIPTASE REVERSA DA TELOMERASE; TELOMERO; TUMORIGENESIS; TRANSFORMACAO; CANCER |
| 26632/34347 | US=92 / Biol/Mol Murnane JP. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: the role of telomeres in genomic instability. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 173-89. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. AMPLIFICACAO; FUSAO CROMOSSOMICA; ELIMINACAO; DUPLICACAO; INSTABILIDADE GENOMICA; ISOCHROMOSOME; TELOMERO; TRANSLOCACAO |
| 26633/34347 | US=92 / Biol/Mol Dupré A, Gautier J. DNA damage response, signalling pathways, and tumorigenesis: overview of the DNA damage checkpoint. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 193-221. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ATM; ATR; CHECKPOINTS; REPLICA; CADEIA SIMPLES DE DNA; REPARO DE QUEBRA DE DUPLA FITA DO DNA |
| 26634/34347 | US=92 / Biol/Mol Maclean KH, Cleveland JL. DNA damage response, signalling pathways, and tumorigenesis: interactions between Myc- and cyclin-dependent kinase inhibitors in cancer. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 223-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 26635/34347 | US=92 / Biol/Mol Chronis F, Ragakou EP. DNA damage response, signalling pathways, and tumorigenesis: interplay between yH2AX and 53BP1 pathways in DNA double-strand break repair response. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 243-63. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. H2AX; 53BP1; REPARO DE DNA; QUEBRAS DE DUPLA VERTENTE; CROMATINA |
| 26636/34347 | US=92 / Biol/Mol Povirk LF. DNA damage response, signalling pathways, and tumorigenesis: DNA-dependent protein kinase in repair, apoptosis, telomere maintenance, and chemotherapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 265-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ACABAR JUNTANDO RADIACAO; RUPTURAS DE FILAMENTOS DUPLOS; REPARO DO DNA; KU; ARTEMIS; REPARACAO FOCOS |
| 26637/34347 | US=92 / Biol/Mol Dent P, Curiel DT, Fisher PB. Resistance and sensitization: resistance/signaling pathways. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 281-98. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. RADIACAO; SINALIZACAO; QUINASE; FOSFATASE; ESPECIES REATIVAS DE OXIGENIO / NITROGENIO; RECEPTOR |
| 26638/34347 | US=92 / Biol/Mol Cabot MC. Resistance and sensitization: ceramide and multidrug resistance. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 299-312. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. CERAMIDA; QUIMIOTERAPIA; MULTIRRESISTENCIA; GLICOSILCERAMIDA SINTETASE |
| 26639/34347 | US=92 / Biol/Mol Smith DL, Nolden LK, Mills GB, Lu Y. Resistance and sensitization: chemo-and radiosensitization through inhibition of PI3K/Akt signaling. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 313-34. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. FOSFATIDILINOSITOL 3-QUINASE; AKT; SIGNALTRANSDUCTION; TERAPIA ALVO MOLECULAR; QUIMIOSSENSIBILIZACAO; RADIOSSENSIBILIZACAO |
| 26640/34347 | US=92 / Biol/Mol Allen GW, Harari PM. Resistance and sensitization: the advancement of epidermal growth factor receptor inhibitors in cancer therapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 335-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; RADIACAO; APOPTOSE; INIBIDORES DE MOLECULAS PEQUENAS; ANTICORPOS MONOCLONAIS |